402
Views
12
CrossRef citations to date
0
Altmetric
Research Article

The Immunological Properties of Stroma-free Polyhemolysate Containing Catalase and Superoxide Dismutase Activities Prepared by Polymerized Bovine Stroma-free Hemolysate

, , &
Pages 57-63 | Published online: 08 Mar 2010

REFERENCES

  • Aebi, H. (1974). UV-assay of catalase. H.U. Bergmeyer. Methods of Enzymatic Analysis, vol. 2, Verlag Chemie, Weinheim, Germany, 673.
  • Alayash, A.I., D’Agnillo, F., Buehler, P.W. (2007). First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin. Biol. Ther. 7(5): 665–675.
  • Burger, R., Zilow, G., Bader, A., Friedlein, A., Naser, W. (1988). The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. The Journal of Immunology 141(2): 553–558.
  • Chang, T.M.S. (1964). Semipermeable microcapsules. Science 146(3643): 524.
  • Chang, T.M.S. (1971). Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common. 44(6): 1531–1536.
  • Chang, T.M.S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials. vol. 1. Karger, Basel (full text available for free online viewing at www.artcell.mcgill.ca).
  • Chang, T.M.S. (2005). Therapeutic applications of polymeric artificial cells. Nature Review: Drug Discovery 4: 221–235.
  • Chang, T.M.S. (2006). Blood substitutes based on nanobiotechnology. TRENDS in Biotechnology 24(8): 372–377.
  • Chang, T.M.S. (2007). Artificial Cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, and Cell/Stem Cell Therapy, vol. 1 of Regenerative Medicine, Artificial Cells and Nanomedicine, World Scientific, Singapore.
  • Chang, T.M.S., Lister, C.W. (1990). C3a complement activation in human plasma. Biomaterials, Artificial Cells, and Artificial Organs 18(5): 693–701.
  • Chang, T.M.S., Lister, C.W. (1994). Assessment of blood substitutes: II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical Aanalysis. Artificial Cells, Blood Substitutes and Biotechnology 22(2): 171–180.
  • Chang, T. M. S., D’Agnillo, F., Yu, W.P., Razack, S. (2000). Two future generations of blood substitutes based on polyhemoglobin–SOD–catalase and nanoencapsulation. Advanced Drug Delivery Reviews 40: 213–218.
  • D'Agnillo, F., Chang, T.M.S. (1998). Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nature Biotechnology 16: 667–671.
  • Domagk, Süleyman Gezici, Götz, F. (1979). Glucose-6-phosphate dehydrogenase from bovine erythrocytes: Kinetic properties and the electrophoretic comparison of its subunit structure with g6pdh from other sources. International Journal of Biochemistry 10(5): 427–432.
  • D'Souza, A., Kurien, B.T., Rodgers, R., Shenoi, J., Kurono, S., Matsumoto, H., Hensley, K., Nath, S.K., Scofield, R.H. (2008). Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Medical Genetics 9(62): 1–8.
  • Feinstein, R. N., Suter, H., Jaroslow, B.N. (1968). Blood catalase polymorphism: some immunological aspects. Science 159: 638–640.
  • Feinstein, N. R. (1949). Perborate as sunstrate in a new assay of catalase. The Journal of Biological Chemistry 180(3): 1197–1202.
  • Forman, H. J., Fridovich, I. (1973). On the stability of bovine superoxide dismutase. J. Biol. Chem. 248: 2645–2649.
  • Freedman, S, Anderson, P., Epstein, D. (1985). Superoxide dismutase and catalase of calf trabecular meshwork. Invest Ophthalmol Vis Sci 26: 1330–1335.
  • Gould, S. A. . (2002). The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 195: 445–452.
  • Gu, J., Chang, T.M.S. (2009). Extraction of erythrocyte enzymes for the preparation of polyhemoglobincatalase-superoxidase dismutase. Artificial Cells, Blood Substitutes, and Biotechnology 37: 69–77.
  • Hanset, M., Ansay, R. (2009). Purine nucleoside phosphorylase (NP) of bovine erythrocytes: genetic control of electrophoretic variants. Animal Genetics 3(4): 219–227.
  • Harkness, D.R., Villa, L., Berman, I., Wilson, J.B., Huisman, T.H.J. (1977). Biosynthetic and structural studies of hemoglobin in a patient with congenital dyserythropoietic anemia Type I. Hemoglobin 1(7): 663–677.
  • Hultquist, R. H., Douglas, D. E. (1978). Evidence that two forms of bovine erythrocyte cytochrome b5 are identical to segments of microsomal cytochrome b5. Proc Natl Acad Sci U S A 75(7): 3118–3122.
  • Jahr, J.S., Mackenzie, C., Pearce, L.B., Pitman, A., Greenburg, A.G. (2008). HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopaedic surgery. J Trauma 64: 1484–97.
  • Tian, J., Xu, Z., Smith, J.S., Hofherr, S.E., Barry, M.A., Byrnes, A.P. (2009). Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. Journal of Virology 83(11): 5648–5658.
  • McCord, J.M., Keele, Jr., B.B., Fridovich, I. (1971). An enzyme-based theory of obligate anaerobiosis: The physiological function of superoxide dismutase. Proc. Nat. Acad. Sci. USA 68(5): 1024–1027.
  • Moore, E.E., Moore, F.A., Fabian, T.C., Bernard, A.C., Fulda, G.J., Hoyt, D.B., Duane, T.M., Weireter Jr., L.J., Gomez, G.A., Cipolle, M.D., Rodman Jr., G.H., Malangoni, M.A., Hides, G.A., Omert, L.A., Gould, S.A. (2009). Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA multicenter trial. J Am Coll Surg. 208: 1–13.
  • Mun, K. C., Bae, J.H., Suh, S.I., Kim, Y.H., Lee, S.H., Kim, S.P., Kwon, T.K., Hwang, J.S. (2003). Effect of modified polyhemoglobin on the oxidative damage after ischemia-reperfusion in the liver. Transplantation Proceedings 33: 126–127.
  • Pearce, L.B., Gawryl, M.S., Rentko, V.T., Moon-Massat, P.F., Rausch, C.W. (2006). HBOC-201 (Hb Glutamer-250 (Bovine), Hemopure): Clinical studies. Blood Substitutes, Winslow, R. Academic Press, San Diego, 437–4509.
  • Powanda, D., Chang, T.M.S. (2002). Cross-linked polyhemoglobin-superoxide dismutase catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artificial Cells, Blood Substitutes, and Biotechnology 30: 23–37.
  • Simoni, R.D., Hill, R.L., Vaughan, M. (2002). The structure and function of hemoglobin: Gilbert Smithson Adair and the Adair equations. The Journal of Biological Chemistry 277: 20.
  • Beydemir, S., Yilmaz, H., Ciftci, M., Bakan, E., Kufrevioglu, O.I. (2003). Purification of glucose 6-phosphate dehydrogenase from goose erythrocytes and kinetic properties. Turkish Journal of Veterinary & Animal Sciences 27(5): 1179–1185.
  • Torrance, J.D., Whittaker, D., Beutler, E. (1977). Purification and properties of human erythrocyte pyrimidine 5′-nucleotidase. Proc Natl Acad Sci U S A 74(9): 3701–3704.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.